Mesoblast (MESO) Cash from Investing Activities (QoQ) (2016 - 2023)
Mesoblast (MESO) Cash from Investing Activities (QoQ) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Mesoblast | 18.89 Bn | 18.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -40.74% |
| Mar 31, 2023 | 179.41% |
| Dec 31, 2022 | 83.25% |
| Sep 30, 2022 | -331.91% |
| Jun 30, 2022 | 16.07% |
| Mar 31, 2022 | -86.67% |
| Dec 31, 2021 | 69.70% |
| Sep 30, 2021 | 55.61% |
| Jun 30, 2021 | 76.18% |
| Mar 31, 2021 | -129.98% |
| Dec 31, 2020 | -402.47% |
| Sep 30, 2020 | 95.66% |
| Jun 30, 2020 | -169.55% |
| Mar 31, 2020 | -50.98% |
| Dec 31, 2019 | -81.42% |
| Sep 30, 2019 | 68.30% |
| Jun 30, 2019 | -786.67% |
| Mar 31, 2019 | -23.29% |
| Dec 31, 2018 | -87.18% |
| Sep 30, 2018 | 91.06% |